Literature DB >> 8405666

Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution.

H Muramatsu1, H Shirahama, S Yonezawa, H Maruta, T Muramatsu.   

Abstract

Midkine (MK) is a heparin-binding growth factor specified by a retinoic acid responsive gene. A rabbit was immunized against recombinant MK produced in L cells, and the resulting antibody was affinity purified using MK-glutathione S-transferase fusion protein as a ligand. The MK-specific antibody was used to investigate the function and distribution of MK. MK of the same size as the recombinant MK produced in L cells (13 kDa) was strongly detected in a 13-day rat embryo. Weak expression was observed in the brains of a 19-day embryo, neonates, and adults. In the 13-day mouse embryos, high levels of MK were detected on the surfaces of brain cells, as well as in basement membranes and in the epithelial cells of the intestine, the jaw, and the rib. Nerve cells from the brains of 13-day or 19-day rat embryos extended neurites about twofold more efficiently on MK-coated dishes than on poly-L-lysine-coated dishes. Furthermore, anti-MK antibody inhibited neurite extension not only on MK-coated dishes, but also on poly-L-lysine-coated dishes. These results suggest that MK is an endogenous neurite outgrowth factor involved in the development of the central nervous system. Anti-MK antibody was also found to inhibit growth of Wilms' tumor cells, which secreted MK into culture medium. Thus, overproduction of MK is involved in enhanced growth of Wilms' tumor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405666     DOI: 10.1006/dbio.1993.1250

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  51 in total

1.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 2.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.

Authors:  K Meng; A Rodriguez-Peña; T Dimitrov; W Chen; M Yamin; M Noda; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.

Authors:  Li-Cheng Dai; Di-Yong Xu; Xing Yao; Li-Shan Min; Ning Zhao; Bo-Ying Xu; Zheng-Ping Xu; Yong-Liang Lu
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

5.  Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause.

Authors:  Maggie K Diamond-Stanic; Melissa J Romero-Aleshire; Patricia B Hoyer; Kevin Greer; James B Hoying; Heddwen L Brooks
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

6.  Midkine promotes selective expansion of the nephrogenic mesenchyme during kidney organogenesis.

Authors:  Libo Qiu; Deborah P Hyink; William H Gans; Kurt Amsler; Patricia D Wilson; Christopher R Burrow
Journal:  Organogenesis       Date:  2004-07       Impact factor: 2.500

7.  Expression and purification of bioactive high-purity human midkine in Escherichia coli.

Authors:  Zhong-hui Zhang; Li-juan Du; Di Xiang; Shun-ying Zhu; Ming-yuan Wu; Hui-li Lu; Yan Yu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

8.  Midkine is highly expressed in neuroblastoma tissues.

Authors:  Henning C Fiegel; Jussuf T Kaifi; Robin Wachowiak; Alexander Quaas; Kuniaki Aridome; Keiko Ichihara-Tanaka; Takashi Muramatsu; Roman Metzger; Jakob R Izbicki; Rudolf Erttmann; Dietrich Kluth; Holger Till
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

9.  Nucleolin: acharan sulfate-binding protein on the surface of cancer cells.

Authors:  Eun Ji Joo; Gerdy B ten Dam; Toin H van Kuppevelt; Toshihiko Toida; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycobiology       Date:  2004-08-25       Impact factor: 4.313

Review 10.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.